Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

Carmen García-De-Vicuña, M. Díaz-Llopis, David Salom, Rosa Bou, Jesús Díaz‐Cascajosa, Miguel Cordero‐Coma, Gabriela Ortega, Norberto Ortego‐Centeno, Marta Suarez-de-Figueroa, Juan Cruz-Martínez,

Mediators of Inflammation · 2013 · 50 citations · 24 references

DOIFull text

Open access

Abstract

Adalimumab seems to be an effective and safe treatment for JIA-associated refractory uveitis and may reduce steroid requirement.

References

24